Safety assessment of sorafenib in Chinese patients with unresectable hepatocellular carcinoma: subgroup analysis of the GIDEON study
暂无分享，去创建一个
Shuijun Zhang | P. Bie | S. Ye | Yunpeng Liu | K. Dou | Jiamei Yang | Jijin Yang | G. Shao | Luming Liu | Yun-fei Yuan | Xiaxing Deng | C. Hao | Jie Zhou | Z. Fu | Fengyong Liu | Xiaoping Chen | Yajin Chen | K. Nakajima | Q. Xia | Zhengguang Lv